Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Eduard Riera-Gil"'
Autor:
Eulalia Valls-Ferrusola, Juan Ramón García-Garzón, Ana Ponce-López, Marina Soler-Peter, Silvia Fuertes-Cabero, Merce Moragas-Solanes, Eduard Riera-Gil, Ignasi Carrió-Gasset, Francisco Lomeña-Caballero
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 104, Iss 7, Pp 360-366 (2012)
Background and aim: currently it is recognized the usefulness of 18F-FDG PET in assessing response to therapy with imatinib (Gleevec®) in the gastrointestinal tract sarcomas (GIST). To facilitate the follow-up of these studies is important to know t
Externí odkaz:
https://doaj.org/article/bdfa9848bcf644e7852d65957af227f8
Autor:
Marina Soler-Peter, Eduard Riera-Gil, Merce Moragas-Solanes, Ana Ponce-López, Silvia Fuertes-Cabero, Juan Ramón García-Garzón, Ignasi Carrió-Gasset, Eulalia Valls-Ferrusola, Francisco Lomeña-Caballero
Publikováno v:
Revista Española de Enfermedades Digestivas v.104 n.7 2012
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Background and aim: currently it is recognized the usefulness of 18F-FDG PET in assessing response to therapy with imatinib (Gleevec®) in the gastrointestinal tract sarcomas (GIST). To facilitate the follow-up of these studies is important to know t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa70de898c7aa0b05e0a8b5c64ffda17
https://doi.org/10.4321/s1130-01082012000700005
https://doi.org/10.4321/s1130-01082012000700005